Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (18)

2024

  1. Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes

    Translational Psychiatry, Vol. 14, Núm. 1

2021

  1. 5-HT4Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression

    ACS Chemical Neuroscience, Vol. 12, Núm. 11, pp. 2036-2044

2020

  1. β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System

    Molecular Neurobiology, Vol. 57, Núm. 3, pp. 1704-1715

2019

  1. Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation

    Molecular Neurobiology, Vol. 56, Núm. 1, pp. 553-566

2018

  1. Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4745-4762

2017

  1. Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation

    ACS Chemical Neuroscience, Vol. 8, Núm. 11, pp. 2393-2401

  2. The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors

    Cerebral Cortex, Vol. 27, Núm. 5, pp. 2809-2819

2016

  1. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors

    Neuropharmacology, Vol. 103, pp. 16-26

  2. The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor

    Neuropharmacology, Vol. 111, pp. 47-58

  3. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration

    Molecular Psychiatry, Vol. 21, Núm. 3, pp. 328-338

2015

  1. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures

    Oncotarget, Vol. 6, Núm. 28, pp. 25452-25465

  2. Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

    Cancer Cell, Vol. 28, Núm. 2, pp. 170-182

2014

  1. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of down syndrome

    PLoS ONE, Vol. 9, Núm. 9

  2. Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity

    Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3776-3794

2013

  1. Neural plasticity and proliferation in the generation of antidepressant effects: Hippocampal implication

    Neural Plasticity, Vol. 2013

2012

  1. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT 4 receptor agonist RS67333

    International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 631-643

  2. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects

    British Journal of Pharmacology, Vol. 165, Núm. 4 B, pp. 1046-1057

2010

  1. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms

    Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434